Weekly ADP improves modestly (Not usually a market mover)
US JOB GROWTH PICKS UP STEAM IN FEBRUARY U.S. PRIVATE EMPLOYERS ADDED AN AVERAGE OF 12,750 JOBS PER WEEK IN EARLY FEBRUARY, ACCORDING TO ADP RESEARCH. THIS MARKS THE FOURTH STRAIGHT WEEK OF ACCELERATING JOB GAINS, SIGNALING A STRENGTHENING LABOR MARKET AFTER A SLOWER START TO THGE YEAr (X)
US PRE-MARKET MOVERS: AMD/META/NVDA, KEYS, HD, KDP, WBD, PYPL, JPM, FANG, NVO/LLY, HIMS
ES -0.1% NQ +0.2% RTY -0.1%
AMD shares spike higher
Meta (META) reportedly signs a blockbuster AMD (AMD) deal to spend billons on AI gear, according to Bloomberg

Newsquawk Daily US Opening News – 24th February 2026
XAUUSD (GOLD) UPDATE
XAUUSD 1 HOUR CHART

USDJPY UPDATE
USDJPY 4 HOUR CHART

Forex Market Snapshot
Elsewhere,
US Data Duel ADP Weekly, House Prices (Dec), Consumer Confidence (Feb), Dallas/Richmond Fed (Feb)

This appears to have been one catalyst for the JPY sell-off
Japanese PM Takaichi reportedly relayed to BoJ Governor Ueda her reservations about further rate hikes, according to Mainichi citing sources
<p style=”text-align: center;”>Source: Try Newsquawk free for 7 days</p>
February 23 Post-Market Earnings Release Stocks
(KEYS) Keysight Technologies reported a 27% revenue increase in its Communications Solutions Group and a 15% rise in the Electronic Industrial Solutions Group, driven by strong sector performance.
(HIMS) Hims & Hers Health, Inc. slid nearly 10% after-hours as the company’s 2026 revenue outlook came in below Wall Street expectations, reviving investor concerns around regulatory risk tied to compounded GLP-1 weight-loss drugs.
(BWXT) BWX Technologies, Inc. revenue grew 18% to $3.2B in 2025, with net income of $329M and strong backlog of $7.26B. Major acquisitions and new debt financing supported expansion, while government contracts and nuclear market demand remain key drivers.



Newsquawk Market Wrap 3
Meanwhile, on trade, Trump lifted his Section 122 tariffs to 15% from 10% over the weekend. Nations like Mexico announced they will now be paying less tariffs on non-USMCA-compliant goods, while the EU has frozen trade talks with the US and is not seeking to alter the pre-existing deal at this stage. Trump has warned that those who decide to play games will be met with a higher tariff than what they recently agreed to. ‘
The risk-off sentiment around AI disruption and also the lifting of tariffs saw T-notes catch a bid throughout the US session to settle around peaks, with eyes turning to supply in a data-light week. However, several central bank speakers are on the docket for Tuesday. Waller spoke today, noting it is almost a coin toss for a cut or a hold in March.
In FX, the Dollar was mixed vs peers while activity currencies lagged in the risk-off trade. Crude prices ultimately settled slightly lower while eyes turn to the US/Iran talks on Thursday. On this, reports suggest the Pentagon has been pushing Trump to go for a diplomatic resolution, warning about the risks of striking Iran. Trump has apparently been leaning towards strikes, but has agreed to give Witkoff and Kushner more time to negotiate for diplomacy. Gold and Silver rallied on the risk conditions, while Bitcoin slumped.s.

Newsquawk Market Wrap 2
was a risk-off session on Monday with equities sliding on fears of further AI disruption, while US President Trump hiked tariffs. The AI fears seemingly sparked from a research piece from Citrini Research exploring severe downside risks if AI exceeds expectations. This is not the firm’s base-case scenario, but it highlighted how unemployment could spike to 10% with the SPX down 38% from late-2026 peaks (which it pencilled in at 8,000) with a recession in 2027. It largely highlighted payments, software and private credit stocks as highly exposed to such a scenario. All of which sectors tumbled on Monday, while IBM also took a chunky hit as Anthropic announced that Claude can now automate COBOL modernisation efforts – further adding to the AI disruption fears.

Newsquawk US Market Wrap 1: Risk-off trade as AI disruption fears mount while Trump hikes tariffs
SNAPSHOT: Equities down, Treasuries up, Crude down, Dollar mixed, Gold up
REAR VIEW: Research firm raises AI disruption fears; Trump raises Section 122 tariffs to 15% from 10%, threatens even higher tariffs; EU Parliament agrees to postpone vote on EU-US trade deal; Fed’s Waller says March decision is a coin toss; Witkoff and Kushner to meet Iran on Thursday; Pentagon pushing Trump for diplomatic approach; US’s Rubio weekend visit to Israel postponed to Monday; Hungary said it will block EU Ukraine decisions until the Druzhba pipeline flow resumes; Novo Nordisk CargriSema trial disappoints; PYPL reportedly attracts takeover interest.
Trump Social Post on Irn:
Numerous stories from the Fake News Media have been circulating stating that General Daniel Caine, sometimes referred to as Razin, is against us going to War with Iran. The story does not attribute this vast wealth of knowledge to anyone, and is 100% incorrect. General Caine, like all of us, would like not to see War but, if a decision is made on going against Iran at a Military level, it is his opinion that it will be something easily won. He knows Iran well in that he was in charge of Midnight Hammer, the attack on the Iranian Nuclear Development. It is a Development no longer, but rather, was blown to smithereens by our Great B-2 Bombers. Razin Caine is a Great Fighter, and represents the Most Powerful Military anywhere in the World. He has not spoken of not doing Iran, or even the fake limited strikes that I have been reading about, he only knows one thing, how to WIN and, if he is told to do so, he will be leading the pack. Everything that has been written about a potential War with Iran has been written incorrectly, and purposefully so. I am the one that makes the decision, I would rather have a Deal than not but, if we don’t make a Deal, it will be a very bad day for that Country and, very sadly, its people, because they are great and wonderful, and something like this should never have happened to them. PRESIDENT DONALD J. TRUMP
US500 UPDATE
US500 1` HOUR CHART

Novo lost share value like it was on its weight loss drug
Feb 23 (Reuters) – Novo Nordisk (NOVOb.CO) shares slumped by more than 16% on Monday, wiping away the remaining gains brought by its blockbuster weight-loss drug Wegovy, after the drugmaker said its next-generation obesity drug CagriSema underperformed Eli Lilly’s (LLY.N) rival.
Novo, which in 2024 was worth more than $650 billion, has since shed around $475 billion, with the shares back at levels last seen before Wegovy transformed it into Europe’s most valuable drugmaker…. Reuters

BTCUSD (BITCOIN) UPDATE
BTCUSD DAILY CHART

© 2024 Global View
